Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.4.3 was added and the previous v3.4.2 was removed from the record history. This update affects revision tracking rather than study content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the history. The funding-lapse notice and the earlier revision note (v3.4.1) were removed.SummaryDifference0.7%

- Check41 days agoChange DetectedAdded a government funding notice and a new revision entry (v3.4.1) to the history, and removed the previous revision entry (v3.4.0).SummaryDifference0.7%

- Check48 days agoChange DetectedThe page history now includes a 'Show glossary' option, green highlights for additions, red highlights for deletions, and an updated revision indicator to v3.4.0.SummaryDifference0.9%

- Check62 days agoChange DetectedThe history now includes a new version entry (v3.3.4) and removes v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a new Revision: v3.3.3 entry; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.